Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01401699 · ClinicalTrials.gov registry record · NA

Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction

A NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
109
Enrollment target
1
Study location

NCT01401699: Completed NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.

NCT01401699 is a NA study of Barrett's Esophagus that has completed, run by Massachusetts General Hospital. The registered enrollment target is 109 participants, below the 519-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01401699, a NA study of Barrett's Esophagus, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

The specific aim of this study is to determine the accuracy of Optical Coherence Tomography (OCT) imaging for screening and diagnosis of the distal esophagus in patients undergoing a clinical esophagogastroduodenoscopy (EGD) procedure. The accuracy of results obtained using the developed OCT imaging probe will be determined and compared with those obtained through the traditional standard of care endoscopic biopsy .

Primary Outcome

Collected entire distal esophagus OFDI Images analyzed and compared to the images obtained during standard of care surveillance endoscopy.

Conditions Studied

Interventions

  • DEVICE Optical Frequency Domain Imaging (OFDI)

Study Locations (1)

Massachusetts

  • Massachussetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2006-09
Est. Completion 2011-11-16
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT01401699 record still lists

NCT01401699 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 519-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Optical Frequency Domain Imaging (OFDI) is the first listed.

NCT01401699 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01401699 about?

NCT01401699 is a clinical study titled "Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction". The specific aim of this study is to determine the accuracy of Optical Coherence Tomography (OCT) imaging for screening and diagnosis of the distal esophagus in patients undergoing a clinical esophagogastroduodenoscopy (EGD) procedure. The accuracy of results obtained using the developed OCT imaging...

What is the current status of trial NCT01401699?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2006-09. Estimated completion is 2011-11-16.

What conditions does trial NCT01401699 study?

This clinical trial studies the following conditions: Barrett's Esophagus.

What interventions are being tested in trial NCT01401699?

The interventions under investigation include: Optical Frequency Domain Imaging (OFDI) (DEVICE).

Who is sponsoring clinical trial NCT01401699?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01401699 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Barrett's Esophagus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01401699's enrollment target sits among peer trials

109 9th of 22 higher than 14 of 22 other Barrett's Esophagus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Barrett's Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01401699, the US trial registry maintained by the National Library of Medicine. NCT01401699 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.